Important news for program participants regarding the GlaxoSmithKline (GSK) Commitment to Access Patient Assistance Program
GSK recently sold their marketed oncology and certain specialty medicines to Novartis Pharmaceuticals Corporation. This sale will not affect your current participation in the CTA Patient Assistance Program and you will continue to receive your medication under the program. GSK and Novartis share a commitment to help eligible individuals who are uninsured and/or underinsured get the medicines they need. For now, GSK will continue to manage the CTA program to ensure a smooth transfer later in the year to Novartis.
There are no actions for you to take right now. You will be notified when the transition of the program will take place and will be provided more information at that time.
If you have any questions about your enrollment in CTA Patient Assistance Program, please call the GSK helpline at 1-866-265-6491 between the hours of 8:30am-8pm EST.
To begin the enrollment process for GSK cancer or certain specialty medicines and determine your eligiblity.
GSK Counselors are available to assist you from 8:30am - 8:00pm EST at:
Assistance is available in Spanish and many other languages / La asistencia está disponible en español y muchos otros idiomas.